PROTHIADEN

This brand name is authorized in France, Ireland, Japan, Netherlands, South Africa, UK.

Active ingredients

The drug PROTHIADEN contains one active pharmaceutical ingredient (API):

1	Dosulepin UNII 3H0042311V - DOTHIEPIN HYDROCHLORIDE
	Dosulepin is a tricyclic antidepressant which acts by inhibiting the re-uptake of monoamine neurotransmitters into presynaptic neurone at central nervous system, so producing a clinical antidepressant effect. Dosulepin, in common with other tricyclics, inhibits the reuptake of noradrenaline and 5-hydroxytryptamine, with a significantly greater action on the uptake of noradrenaline.
	Read more about Dosulepin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PROTHIADEN Capsule, hard	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AA16	Dosulepin	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AA Non-selective monoamine reuptake inhibitors
Discover more medicines within N06AA16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	61962852, 69699339
GB	Medicines & Healthcare Products Regulatory Agency	126600, 14515, 175896
IE	Health Products Regulatory Authority	43168, 71269, 74861
JP	医薬品医療機器総合機構	1179027F1025
NL	Z-Index G-Standaard, PRK	19739, 20885
ZA	Health Products Regulatory Authority	F/1.2/161, K/1.2/3